Clinical Trial

OM336 in Autoimmune Cytopenias

Name: OM336 in Autoimmune Cytopenias — clinical trial record (NCT07083960)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

An early-phase clinical trial evaluating the safety, tolerability, and pharmacokinetics of subcutaneously dosed OM336 in adult participants with autoimmune cytopenias.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-07-17; most recent amendment 2026-07-13.

Status change: Not Yet Recruiting → Recruiting 2025-09-24

Trial Details

NCT Number	NCT07083960
Lead Sponsor	Lakefront Biotherapeutics West LLC
Conditions	AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia, ITP - Immune Thrombocytopenia
Enrollment	32 participants
Start Date	2025-08-01
Primary Completion	2026-12 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-14